Varicella-Zoster virus DNA (2 Challenges) EQA/PT Scheme

To assess the ability of laboratories molecular assays to detect different concentrations of Varicella-Zoster virus (VZV).

To review the performance of laboratories quantitative VZV molecular assays.

Total Number of Challenges: 2
Number of Panel Members: 5
Distribution / Testing Period: Q1 and Q3
Sample NA Target Source Cultured virus and/or Clinical material
Matrix Panel Format Transport Medium and/or Synthetic CSF
Panel Member Target Range Covering clinical range
Panel Member Sample Volume 1.0 ml
Panel Sample Pre-treatment Requirement Ready for analysis. Treat as clinical samples and analyse accordingly.
Panel Analysis Type Qualitative. Quantitative for information purposes only
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions <-20°C / Frozen on Dry-ice
Accreditation / Regulatory Status Accredited to ISO 17043

$1,228.58